Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aptamers in Bordeaux, 24-25 June 2016.
Toulmé JJ, Giangrande PH, Mayer G, Suess B, Ducongé F, Sullenger B, de Franciscis V, Darfeuille F, Peyrin E. Toulmé JJ, et al. Among authors: de franciscis v. Pharmaceuticals (Basel). 2017 Jan 20;10(1):14. doi: 10.3390/ph10010014. Pharmaceuticals (Basel). 2017. PMID: 28117671 Free PMC article.
Cell-specific aptamers for targeted therapies.
Cerchia L, Giangrande PH, McNamara JO, de Franciscis V. Cerchia L, et al. Among authors: de franciscis v. Methods Mol Biol. 2009;535:59-78. doi: 10.1007/978-1-59745-557-2_5. Methods Mol Biol. 2009. PMID: 19377980 Free PMC article. Review.
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Among authors: de franciscis v. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Free PMC article. Review.
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.
Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, Swiderski P, Condorelli G, Giangrande PH, de Franciscis V. Esposito CL, et al. Among authors: de vita g, de franciscis v. Mol Ther. 2014 Jun;22(6):1151-1163. doi: 10.1038/mt.2014.5. Epub 2014 Jan 20. Mol Ther. 2014. PMID: 24441398 Free PMC article.
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.
Iaboni M, Russo V, Fontanella R, Roscigno G, Fiore D, Donnarumma E, Esposito CL, Quintavalle C, Giangrande PH, de Franciscis V, Condorelli G. Iaboni M, et al. Among authors: de franciscis v. Mol Ther Nucleic Acids. 2016 Mar 8;5(3):e289. doi: 10.1038/mtna.2016.5. Mol Ther Nucleic Acids. 2016. PMID: 27111415 Free PMC article.
134 results